Larimar Therapeutics Reports Second Quarter 2025 Financial Results

Go back to Larimar Therapeutics Reports Second Quarter 2025 Financial Results
(NASDAQ: LRMR) Delayed: 3.60 --0 (-0%)
Previous Close $3.60    52 Week High
Open $3.60    52 Week Low
Day High $3.60    P/E N/A 
Day Low $3.60    EPS
Volume 574